Peptide Libraray

Sequence 39 from Patent US 20110159022

General Information

DCTPep ID DCTPep01346

Peptide Name Sequence 39 from Patent US 20110159022

Sequence LTLGEFLKL

Sequence Length 9

UniProt ID O15392 A6Q6T6

PubChem CID Not available

Origin Synthetic construct

Type Synthetic peptide

Classification

ACP

Activity Information

Hemolytic Activity Not available

Normal (non-cancerous) Cytotoxicity Not available

Target Not available

Affinity Not available

Mechanism Not available

Structure Information

PDB ID Not available

Predicted Structure Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity Not available

Linear/Cyclic Not available

Disulfide/Other Bond Not available

N-terminal Modification Not available

C-terminal Modification Not available

Other Modification None

Chiral L

Physicochemical Information

Formula C50H84N10O13

Absent amino acids ACDHIMNPQRSVWY

Theoretical pI 6.00

Acidic residues 1

Basic residues 1

Polar residues 2

Molecular weight (Average) 1033.28

Molecular weight (Monoisotopic) 1032.62

Common amino acids L

Net charge 0

Instability index (II) -18.36

Aliphatic index 173.33

Grand average of hydropathicity (GRAVY) 1.056

Half Life
5.5 hours (mammalian reticulocytes, in vitro).
3 min (yeast, in vivo).
2 min (Escherichia coli, in vivo).

Extinction coefficients
Should not be visible by UV spectrophotometry.

Amino acid distribution

Literature Information

Literature 1

Pubmed ID Not available

Title Not available

Doi Not available

Year Not available

Patent

Patent ID US 2011/0159022 A1

Patent Title Immunogenic Peptides Derived from the Midkine Protein, as an Anticancer Vaccine.

Other Iinformation Granted Patent Family: 9s / 9ex; Family Jurisdictions: EP, US, JP, CN, CA, AU, WO, FR; Legal Status: Discontinued; Application No: 200913000302; Filed:Jun 20, 2009; Published: Jun 30, 2011; Earliest Priority: Jun 20, 2008;

Other Published ID CA2728459A1 CN102123731A EP2296697A1 WO2009153463A1